Skip to main content
EyeGene,Inc logo

EyeGene,Inc — Investor Relations & Filings

Ticker · 185490 ISIN · KR7185490000 KO Professional, scientific and technical activities
Open in API
Filings indexed 314 across all filing types
Latest filing 2021-05-18 Investor Presentation
Country KR South Korea
Listing KO 185490

About EyeGene,Inc

https://eyegene.co.kr/en/

EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.

Recent filings

Filing Released Lang Actions
[기재정정]투자설명서
Investor Presentation Classification · 95% confidence The document is a 'Correction Report' (정정신고) for an 'Investment Prospectus' (투자설명서). It explicitly states that it is a correction made due to the submission of the 2021 Q1 report. In the context of financial filings, a document that amends or corrects a previously filed prospectus is classified as a regulatory filing related to capital/financing activities. Since it is a formal amendment to a prospectus, it falls under the category of Regulatory Filings (RNS) as it does not fit into the specific report types like 10-K or IR, and it is not a simple announcement of a report.
2021-05-18 Korean
투자설명서
Capital/Financing Update Classification · 100% confidence The document is a 'Investment Prospectus' (투자설명서) for a capital increase (rights offering) by Eyegene Inc. It details the offering price, subscription period, payment date, and provides extensive information on investment risks, business operations, and financial status. This document is a formal regulatory filing related to a capital raise, which falls under the 'Capital/Financing Update' category.
2021-05-17 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding of Stocks, etc.), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (pledges) by major shareholders and special related parties of the company 'Eyegene Inc.' (아이진(주)). This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2021-05-17 Korean
분기보고서 (2021.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for Eyegene Inc. covering the period from 2021-01-01 to 2021-03-31. It contains detailed financial information, company overview, capital changes, and management details, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2021
2021-05-17 Korean
유상증자1차발행가액결정
Capital/Financing Update Classification · 100% confidence The document is an official announcement from the company 'Eyegene' regarding the determination of the '1st issue price' for a capital increase (paid-in capital increase/rights offering). It details the calculation methodology, the specific price per share, and the timeline for the final price determination. This falls under the category of capital and financing updates, specifically related to share issuance and capital structure changes.
2021-05-12 Korean
[기재정정]주요사항보고서(유무상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) from Eyegene Inc. regarding a decision on paid-in and free capital increases (유무상증자결정). It details the issuance of new shares, pricing, allocation ratios, and the purpose of the capital raise. This type of filing is a formal regulatory disclosure regarding changes to the company's capital structure and share issuance, which falls under the 'Share Issue/Capital Change' category.
2021-05-12 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.